Search

Your search keyword '"van Dongen A"' showing total 412 results

Search Constraints

Start Over You searched for: Author "van Dongen A" Remove constraint Author: "van Dongen A" Journal leukemia Remove constraint Journal: leukemia
412 results on '"van Dongen A"'

Search Results

1. The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category

2. Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines

3. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS

4. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

6. Differentiation stage of myeloma plasma cells: biological and clinical significance

7. Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

8. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

10. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

12. The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS

13. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation

15. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

26. Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

29. New insights to the MLL recombinome of acute leukemias

31. Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients

34. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

36. Childhood secondary ALL after ALL treatment

42. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

43. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

49. The MLL recombinome of acute leukemias

Catalog

Books, media, physical & digital resources